0001628280-24-001164.txt : 20240111 0001628280-24-001164.hdr.sgml : 20240111 20240111161011 ACCESSION NUMBER: 0001628280-24-001164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240109 FILED AS OF DATE: 20240111 DATE AS OF CHANGE: 20240111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schaeffer Orlov S Nicole CENTRAL INDEX KEY: 0001401017 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 24529357 MAIL ADDRESS: STREET 1: INSMED INCORPORATED STREET 2: 10 FINDERNE AVENUE CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 4 1 wk-form4_1705007402.xml FORM 4 X0508 4 2024-01-09 0 0001104506 INSMED Inc INSM 0001401017 Schaeffer Orlov S Nicole 700 US 202/206 BRIDGEWATER NJ 08807 0 1 0 0 Chief People Strategy Officer 1 Common Stock 2024-01-09 4 M 0 503 20.49 A 105652 D Common Stock 2024-01-09 4 S 0 503 29.56 D 105149 D Common Stock 2024-01-09 4 S 0 3165 28.74 D 101984 D Stock Option (right to buy) 20.49 2024-01-09 4 M 0 503 0 D 2024-01-10 Common Stock 503 0 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. This is the weighted average sales price representing 3,165 shares sold at prices ranging from $28.72 to $28.74 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. /s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact 2024-01-11